NTES [NetEase,] SC 13G:
[]
NTES [NetEase,] CORRESP: (Original Filing)
[[Letterhead of NetEase.com, Inc.] November 7, 2011 Mr. William H. Thompson Mr. Adam Phippen Division of Corporation Finance 100 F Street, N.E. Re: NetEase.com, Inc. (the Company) Form 20-F for the Fiscal Year Ended December 31, 2010 Filed June 22, 2011 File No. 0-30666 (the 2010 Form 20-F) Dear Mr. Thompson and Mr. Phippen: Staff Commission The Company is providing]
NTES [NetEase,] CORRESP: [Letterhead of NetEase.com, Inc.] November 7, 2011 Mr.
[[Letterhead of NetEase.com, Inc.] November 7, 2011 Mr. William H. Thompson Mr. Adam Phippen Division of Corporation Finance 100 F Street, N.E. Re: NetEase.com, Inc. (the Company) Form 20-F for the Fiscal Year Ended December 31, 2010 Filed June 22, 2011 File No. 0-30666 (the 2010 Form 20-F) Dear Mr. Thompson and Mr. Phippen: Staff Commission The Company is providing]
NTES [NetEase,] SC 13G: CUSIP No.64110W102 13G Page 2 of18 Pages 1
[CUSIP No.64110W102 13G Page 2 of18 Pages 1 NAMES OF REPORTING PERSONS Loneruce, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A o (a) x (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH]
NTES [NetEase,] CORRESP: (Original Filing)
[[Letterhead of NetEase.com,Inc.] November7, 2011 Mr.William H. Thompson Mr.Adam Phippen Division ofrporation Finance 100 F Street, N.E. Re: NetEase.com,Inc. (thempany) Form20-F for the Fiscal Year Ended December31, 2010 Filed June22, 2011 File No.0-30666 (the 2010 Form20-F) Dear Mr.Thompson and Mr.Phippen: Staffmmission Thempany is providing the following information in response to themment letterted October26, 2011 received]
NTES [NetEase,] CORRESP: [Letterhead of NetEase.com,Inc.] November7, 2011 Mr.William H. Thompson
[[Letterhead of NetEase.com,Inc.] November7, 2011 Mr.William H. Thompson Mr.Adam Phippen Division ofrporation Finance 100 F Street, N.E. Re: NetEase.com,Inc. (thempany) Form20-F for the Fiscal Year Ended December31, 2010 Filed June22, 2011 File No.0-30666 (the 2010 Form20-F) Dear Mr.Thompson and Mr.Phippen: Staffmmission Thempany is providing the following information in response to themment letterted October26, 2011 received]
CLNT [Cleantech Solutions International,] 8-K: (Original Filing)
[FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): November 3, 2011 CLEANTECH SOLUTIONS INTERNATIONAL, INC. Delaware 001-34591 74-2235008 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employee Identification No.) No. 9 Yanyu Middle Road Qianzhou Village, Huishan District, Wuxi City Jiangsu Province, People’s Republic of China (86) 51083397559 Copies to: Asher S.]
NTES [NetEase,] SC 13G: CUSIP No.64110W102 13G Page 2 of18 Pages 1
[CUSIP No.64110W102 13G Page 2 of18 Pages 1 NAMES OF REPORTING PERSONS Loneruce, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A o (a) x (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH]
NTES [NetEase,] CORRESP: (Original Filing)
[[Letterhead of NetEase.com,Inc.] November7, 2011 Mr.William H. Thompson Mr.Adam Phippen Division ofrporation Finance 100 F Street, N.E. Re: NetEase.com,Inc. (thempany) Form20-F for the Fiscal Year Ended December31, 2010 Filed June22, 2011 File No.0-30666 (the 2010 Form20-F) Dear Mr.Thompson and Mr.Phippen: Staffmmission Thempany is providing the following information in response to themment letterted October26, 2011 received]
MR [Mindray Medical International] 6-K: (Original Filing)
[Mindray Announces Third Quarter 2011 Financial Results Shenzhen, China November 7, 2011 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September 30, 2011. Highlights for Third Quarter 2011 - Net revenues were $218.4 million, up 29.8% over the] [Mindray Announces Up to $100 Million Share Repurchase Program Shenzhen, China November 7, 2011 Mindray Medical International Limited (Mindray or Company, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved a share repurchase program. The share repurchase program is authorized to be in effect through December]
